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Abstract:
Background:  People with arthritic disease are advised to
participate in gentle exercise on a regular basis, and pursue
long-term medication regimes.  Alternative therapies are
also used by people with arthritis, and may sometimes be
recommended by rheumatologists and other medical
personnel.  Alternative therapies may be divided into two
types: active therapies, in which the patient takes a driving
role, and passive therapies, in which the therapy cannot
proceed unless driven by a therapist.
Objective:  To review the effectiveness of manual therapy
in improving the health-related quality of life (HRQOL)
of people with two common arthritis conditions:
Osteoarthritis and rheumatoid arthritis.
Discussion:  Massage, and other passive (practitioner-
driven) manual therapies, have been anecdotally reported
to improve health-related quality of life (HRQOL) in
people with arthritis.  Many manual therapists consult with
patients who have arthritic diseases, receive referrals from
rheumatologists, and consider the arthritic diseases to be
within their field of practise.  Although there is empirical
evidence that manual therapy with some types of arthritis
is beneficial, the level of effectiveness however is under-
researched.  Medical authorities are reluctant to endorse
manual therapies for arthritis due to a lack of scientific
evidence demonstrating efficacy, safety, and cost
effectiveness.
Keywords:  Health-related quality of life (HRQOL),
osteoarthritis, rheumatoid arthritis, manual therapy.
INTRODUCTION
Arthritides (diseases which cause the symptom picture
known as “arthritis”) are chronic illnesses that significantly
influence the quality of life of both those with the disorder
and people around them.  There are over 100 forms of
arthritis, and the clinical presentations of arthritides vary
substantially both between and within forms1.  The
pathogeneses of arthritic diseases are not well understood2,3,
and although there are disease modifying drug therapies
that might slow or arrest disease progression, no cures
have been discovered or developed to date.  People with
arthritides experience chronic, incurable, progressive
illnesses, and must adapt their lives and daily activities
accordingly.
Osteoarthritis (OA) and rheumatoid arthritis (RA) are the
two most common forms of arthritic disease.  Some OA
may be considered a part of the normal aging process that
affects all humans if they live long enough, but some
people develop OA in middle age or earlier, or experience
considerable pain and disability with OA1.  These people
often seek the assistance of health care professionals to
manage their OA, and in them OA may be viewed as a
disease.
RA is a clearly identified disease process.  The clinical
presentation and symptom picture of this disease have
been well documented2, but its cause is not clear.  RA is a
multi-system disease that may cause dysfunction,
destruction, and eventual failure in organs far removed
from the skeletal system.  People living with RA may
experience loss of functional capacity and diminished
quality of life, not only due to joint and bone damage, but
also due to damage of the heart, lungs, kidneys, or
intestines2.
Typically, outpatient (non-hospitalised) medical care for
people with arthritides comprise an array of medications,
usually provided under the care of a rheumatologist1,3,4.
Medications for arthritis can be grouped into three classes,
each with a different therapeutic purpose:
(a) Analgesics, to reduce or limit pain5,
(b) Non-steroidal anti-inflammatory drugs (NSAIDs), to
reduce inflammation in joints and surrounding tissues5,
(c) Disease modifying anti-rheumatic drugs (DMARDs),
to modify the course of the disease by preventing joint
and tissue damage4.
Several generations of each drug type are now available.
Individuals with arthritis may trial different drug regimes
before settling upon the combination that suits them best.
People with arthritis also use alternative and
complementary therapies (e.g., dietary supplements, yoga,
manual therapies, homoeopathy, acupuncture), and
IS MANUAL THERAPY A RATIONAL APPROACH
TO IMPROVING HEALTH-RELATED QUALITY OF
LIFE IN PEOPLE WITH ARTHRITIS?
Melainie Cameron  B.App.Sc.(Ost.), M.H.Sc. *
*
Printing Requests:
Department of Health Science, Victoria University.
Correspondence:
Osteopathic Medicine Unit.  School of Health Science,
Victoria University. PO Box 14428, Melbourne MC 8001
Email:  Melainie.Cameron@vu.edu.au
Section 1:  Original Articles: Reviews and ExperimentalACO
10 Volume 10 • Number 1 • July 2002
sometimes these therapies are recommended by
rheumatologists and other medical personnel1.  Alternative
therapies may be divided into two types: active therapies,
in which the individual takes a driving role, and passive
therapies, in which the therapy cannot proceed unless
driven by a therapist.
For the past several years, exercise and other active
(client-driven) forms of therapy have been used to improve
the health-related quality of life (HRQOL) of people with
arthritis.  Lorig’s doctoral work was vital to the widespread
acceptance of exercise as a therapy for people with arthritis6.
The Arthritis Foundation of Victoria (AFV) presently
offer to members a range of land and water-based exercise
classes that stem from Lorig’s work.
Massage, and other passive (practitioner-driven) manual
therapies, have been reported, anecdotally, to improve
health-related quality of life in people with arthritis.
Many manual therapists consult with patients who have
arthritic diseases, receive referrals from rheumatologists,
and consider the arthritic diseases to be within their field
of practice.  Health-related quality of life, functional
disability due to arthritis, and self-reported pain are key
measures of therapy effectiveness in the arthritides, and
tools for measuring these outcomes are readily available.
Nevertheless, the efficacy and effectiveness of manual
therapies for specific arthritic complaints is under-
researched.  The AFV and other authorities are reluctant
to endorse manual therapies for arthritis due to a lack of
scientific evidence demonstrating efficacy, safety, and
cost effectiveness1,7.
REVIEW OF LITERATURE
OA and RA are characterised by chronic pain and
progressive physical impairment of joints and soft tissues
(e.g., muscles, tendons).  These diseases are costly to
individuals and society in economic, social, and
psychological terms.
SOCIAL AND ECONOMIC CONSEQUENCES OF
ARTHRITIS
Broad-based estimates of the public health impact of
arthritic diseases on the Australian population are not
readily available.  The Arthritis Foundation of the USA1
reported that OA is a universal problem of humans,
directly affecting approximately 1% of the adult population.
Peyron and Altman demonstrated, however, that the
prevalence of OA varies between racial groups8.  Their
epidemiological investigation revealed that in British
Caucasians aged over 35 years, 70% of women and 69%
of men displayed diagnostic features of OA.  Among
Alaskan Eskimos aged over 40 years, however, the same
features were identified in only 24% of women and 22%
of men.
RA has a worldwide distribution and involves people of all
ethic groups.  Depending upon the stringency of the
diagnostic criteria used in population-based studies,
prevalence estimates vary between 0.3% and 1.5% of the
North American adult population1.  Regardless of the
precise figures, there is consensus that arthritides are a
significant international health problem with considerable
impact on the quality of human life6.
Economic costs of arthritis are both direct (i.e., dollars
spent on medical care) and indirect (e.g., wages lost
through reduced capacity for paid work).  Yelin and
Callahan reported that the economic impact of all forms of
arthritis on the USA economy during 1992 was $15.2
billion USD in direct medical costs and $49.6 billion USD
in indirect costs9.  Arthritis seriously impairs work ability
and leads to reduced individual and household incomes.
Meenan, Yellin, Nevitt, and Epstein found that people
with RA had a 50% decline in earnings over a 9-year
period, accounting for an average 37% reduction in family
income10.
Furthermore, arthritis has considerable influence on other
facets of life, to which it is much harder to ascribe
monetary values.  Pain in joints and muscles is associated
with disuse and physical disability (e.g., inability to bend,
lift, grasp objects).  Physical disability may impair activities
of daily living and produce social and psychological
withdrawal.  Physical and social disabilities are connected
with impaired personal care activities, household tasks,
hobbies, work, and civic activities1.
Pain is a highly subjective phenomenon, and may produce
emotional as well as physical responses11.  Pain is a feature
of all types of arthritis disease, but is not a consistent
marker of any physiological or pathological process1.  A
person with RA may complain of joint pain with or without
associated joint swelling, redness, and heat production
that are the hallmarks of joint inflammation.  Pain, however,
is probably one of the central features of reduced quality
of life for those with arthritis.
The sequelae of arthritis are complex, and probably
interdependent.  Pain may produce physical disability,
which in turn produces social disability, which
compromises health-related quality of life.  Joint and
muscle disuse resulting from physical disability produces
muscle atrophy, bone density loss, and may lead to further
pain6.  When investigating the effectiveness of any therapy
for arthritis, a range of outcome measures may be used to
record the overlapping phenomena of HRQOL, pain, and
physical and social function.
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THERAPIES FOR ARTHRITIS
The causes of arthritides are unknown.  Although there are
some drug treatments associated with reduced severity
and duration of symptoms, no therapies clearly and
consistently arrest the natural courses of these diseases.
Some people experience spontaneous and complete arrest
of arthritic symptoms, but this phenomenon cannot be
directly attributed to drug treatment.  Improvements in
quality of life and functional ability are usually the main
goals of treatment.  Kavanaugh argued that improvement
in quality of life is a key goal of therapy for patients with
RA4.  Simon also argued the same case for patients with
OA5, and summarised the ethos of current care approaches.
Given that most patients must learn to live with a disease
that may significantly alter their earning potential, basic
function, and lifestyle, it is important to develop a treatment
system that views the patient as a whole.  This is achieved
by using methods enlisting the patient’s enthusiasm for
therapy and allowing them to participate in their own
care5(p.26).  Exercise programs and self-administered drug
regimes fit comfortably into this client-driven model of
care.
EXERCISE AS THERAPY
The relationship between exercise and health, in both
clinical and non-clinical populations, has been widely
researched and well documented12.  Physical activity is
associated with improvement in key markers of
psychological well-being and HRQOL, including mood,
self-perception, anxiety, depression, and subjective well-
being13.  The exact processes by which exercise promotes
changes in psychological well-being and HRQOL are
uncertain, but the value of exercise for enhancing mental
and physical health is well supported by research.
Physical inactivity leads to substantial negative effects on
health, including muscle weakness, atrophy, and fatigue.
Leading a sedentary life may also compound the loss of
quality of life associated with chronic illness.  Inactivity is
well correlated with depressed mood, reduced sociability,
and a decline in well-being13.
A wealth of literature supports the use of structured
exercise programmes for people with arthritides.  Van den
Ende, Vliet Vlieland, Munneke, and Hazes conducted a
systematic review to determine the effectiveness of
structured, aerobic exercise on functional outcomes in
people with RA14.  Only four of the 30 studies reviewed
met both inclusion and methodological criteria, and because
of heterogeneity of outcome measures, data could not be
pooled.  They concluded, however, that structured aerobic
exercise programmes were effective in increasing aerobic
capacity and muscle strength in people with RA, and
produced no detrimental effects on disease activity or
pain, but had no conclusive effects on functional ability
(activities of daily living) or radiological (x-ray) markers
of disease progression.  They further argued that these
results meant that structured exercise programmes
increased physical capacity in people with RA.  There is
room to question the value of increased physical capacity
if the ability to undertake activities of daily living does not
correspondingly increase.  To be physically fitter, but no
better able to conduct daily tasks, may be a frustrating
paradox of outcomes for people living with RA.
Conclusions regarding efficacy may be misleading if
drawn solely from tests of statistical significance.  In
studies with small sample sizes, differences between
intervention and control groups may be small (i.e., not
statistically significant) due to low statistical power.  The
reader is better able to make a judgement of the practical
importance of an insignificant intervention if effect size is
also reported15.  The Van den Ende et al. study was not
meta-analytical and they did not report the effect size of
structured exercise on any of the outcomes reviewed14.
The arthritis self-management programme (ASMP)
developed by Lorig and Fries has been widely adopted in
Australia and internationally6.  Regular, gentle exercise,
without altering typical drug therapy (i.e., analgesics,
NSAIDS, DMARDs), is the mainstay of this programme.
Exercise programmes recommended by the AFV for people
with arthritis include exercise in water, tai chi, low-impact
land-based aerobics, and seated aerobics (i.e., exercise in
a chair).
CLIENT-DRIVEN THERAPIES
Treatments emphasising self-management have become
commonly accepted alternative therapies for people with
many types of chronic pain and disease, arthritis included.
Kerns and Rosenberg, however, identified that client-
driven therapies may fail to engage a portion of the
targeted population, and are associated with high drop-out
and relapse rates16.  They found that in a group with
chronic pain, the Pain Stages of Change Questionnaire
could be used to discriminate between those who would
complete a course of client-driven treatment, and those
who would not.  Furthermore, Kerns and Rosenberg
suggested that increased commitment to self-management
for chronic pain might improve the probability of
therapeutic success16.
In a subsequent study, Keefe et al. cluster analysed a
sample of people with RA (n = 103) and OA (n = 74) into
one of five stages of change17.  Sizes of the subgroups were
generally consistent with those expected based upon
Prochaska and DiClemente’s trans-theoretical model of
change18.  Of the 177 people with arthritides Keefe et al.
studied, 55% identified themselves in the pre-
contemplation and contemplation stages of change17.
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People in these early stages of change are unlikely to
participate in self-management therapies for arthritis, but
may be responsive to psycho-educational interventions
aimed at moving them toward contemplation and then
active treatment.
PRACTITIONER-DRIVEN THERAPIES
Practitioner-driven manual therapies may not gain
credibility and acceptance as therapies for people with
arthritis unless they have been demonstrated to improve
quality of life.  These therapies are largely passive.  Clients
attend, and often pay, for treatment, but are not responsible
for developing, planning, or conducting the therapy.  The
practitioner-driven manual therapies draw criticism that
they may reinforce behaviour patterns of dependency and
learned helplessness in clients19.  Not all clients of manual
therapists display dependent behaviours.  Ideally, the
client would report improvement over the course of therapy,
and cease to receive manual therapy when the client and
therapist agree that satisfactory gains have been made.  It
is reasonable to expect that a client who becomes dependant
upon a therapist will report stable functional ability scores
over the course of manual therapy provision because
clients who improve function expect to be discharged
from care.  Worsening functional ability scores may be
reported if for some reason the therapy is curtailed (e.g.,
therapist or patient moves).
Consistent with Simon’s push to view the person with
arthritis as a whole5, proponents of many manual therapies
argue strongly in favour of an holistic approach to care.
Kuchera and Kuchera20, and McKone21 stated that
osteopaths view the human body as a connected unit, and
patients as whole people.  Chengnan argued the same
perspective for practitioners of traditional Chinese massage
therapy22.  Holism is not lacking in the manual therapies,
but the practitioner-driven nature means that therapy may
be “done to” a patient, rather than “engaged in” by a
patient and practitioner.  For people not ready to adopt
self-management approaches, practitioner-driven manual
therapies may offer reasonable, but largely un-tested,
approaches to pain management.
MEASUREMENT ISSUES
In 1992, Kaplan, Coons, and Anderson argued that the
costs of osteoarthritis might be underestimated by
commonly used public health measures (e.g., mortality
rate) because many people with OA live a normal life
span23.  Kaplan, as part of a general health policy model,
proposed the Quality of Well-being Scale (QWB) as a
generic HRQOL outcome measure that could be used to
calculate the cost/utility ratio of interventions, and allow
comparison between interventions of different types and
for different diseases24.  In the QWB scale, functionality
and symptoms are given a weight, derived from community
surveys regarding utility, ranging from 0 (dead) to 1.0
(optimum function).  A score of .64 suggests that an
individual was in an observable state 64% of the way
between optimum functioning and death.  A person
remaining in that state for one year would have lost .36 (1
- .64) well-years (or quality adjusted life years : QALYs).
Using the QWB scale it is possible to estimate the number
of well-years an intervention produces.  Dividing the cost
of the intervention by the well-years produced by that
intervention gives a cost/utility ratio that permits
comparison between interventions and across diagnoses.
Kaplan, Alcaraz, Anderson, and Weisman estimated the
public health impact of OA (in the USA) via a survey
people with self-reported arthritis25.  They estimated the
mean expected QALYs lost because of arthritis to be 1.86.
Measures of QALYs lost to arthritis were greater among
men than women.
Comparison of the cost/utility of interventions across the
breadth of health care is of great interest and importance
to health policy makers and legislators.  Despite the
obvious advantage of the QWB scale, it has not become
widely adopted as a HRQOL outcome measure.  The
general health policy model, comprising the QWB scale,
was trialed in the US State of Oregon between 1987 and
1990.  The policy model failed in Oregon due to several
methodological and analytical flaws associated with
departure from the original design24.  Other generic health
outcome measures, including the Medical Outcomes Study
Short Form 36 (SF-36) and the Sickness Impact Profile,
are used more commonly than the QWB scale in HRQOL
research.  Kaplan, Ganiats, Sieber, and Anderson presented
evidence supporting the validity of the QWB scale for
population monitoring, descriptive studies, and clinical
trials26.  Although the QWB scale is a valid tool for
HRQOL research, Kaplan et al. concluded that the more
widely used SF-36 is a comparable, comprehensive,
alternative tool26.
Many manual therapies have been inadequately
researched, and because of the physical contact
component, these therapies do not fit well into the double-
blind clinical trial model of efficacy research27, making it
difficult to determine the “effective ingredients” in the
therapeutic encounter.  Furthermore, the double-blind
clinical trial, while a gold standard design in drug therapy
research, is removed from the vagaries and complexities
of dealing with human beings in clinical practice.
Manual therapies do offer a rational approach to arthritis
management, and there are research designs suitable to
test the manual therapies.  Despite widespread use, manual
therapies in rheumatology are under-researched.
Conversely, exercise programmes for arthritis care have
been well researched, and provide standards against which
other therapies may be benchmarked.  If we are bold
enough to reconsider the way we conduct health care
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research we may begin to ask clinically appropriate
questions about manual therapies.
MODELS OF RESEARCH FOR MANUAL
THERAPY
Effectiveness, rather than efficacy, is the catch word of
this new type of research.  ‘Efficacy’ is a measure of the
capacity to produce effects.  Conversely, ‘effectiveness’ is
a measure of the production of effects28.  The distinction
is subtle, and important.  Efficacy implies a knowledge of
the mechanism of action of a therapy, and measures the
potential of that therapeutic action to produce desired
health outcomes.  Effectiveness is a simpler measure,
recording whether desired health outcomes are observed,
how often, and in how many participants.  For the most
part in manual therapy, we do not know why patients might
improve, but it is still important to document if and when
they do.
Statistically efficacy and effectiveness differ considerably.
In a clinical trial, efficacy of a therapy is claimed only if
the difference in outcomes between the tested groups is
statistically significant, typically at an alpha level of 0.05
or smaller.  Effectiveness, on the other hand, is reported
via the statistical measure of effect size.  The statistical
significance of difference between groups in a clinical trial
may be grossly influenced by the number of participants
in each groups.  Few participants means low statistical
power in a trial, and thus, little chance of a statistically
significant result.  In short, trials with few participants
are unlikely to demonstrate efficacy of therapy.  Effect
size, the statistical measure of effectiveness, is less
influenced by a group size.  Thus, the effectiveness of a
therapy may be calculated even from pilot studies with
only a handful of participants.
Andersen and Stoove argued that “the sanctity of p = 0.05
obfuscates good stuff” when researchers disregard effect
sizes associated with low risk therapies in clinical trials
with low power resulting from few participants29.
Statistically speaking, the power of a study is the probability
of not making a type 2 error.  In a clinical trial, a type 2
error is drawing the conclusion, based on the statistical
calculations of the trial, that the therapy being tested is not
efficacious, when in truth the therapy works.  Clinical
trials with few participants (i.e., low power) are likely to
yield statistically insignificant results.  Andersen and
Stoove argued that the in the conventional wisdom of
rejecting therapies found to have ‘no efficacy’ (i.e., tests
of statistical significance calculate p as greater than 0.05)
we run the risk of ‘throwing out the baby with the bathwater.’
They rationalise that when the effect sizes associated with
such therapies are medium to large, and the risk of harm to
participants is small, then even ‘non efficacious’ therapies
warrant further investigation because they may by effective.
Furthermore, eminent statisticians maintain that effect
sizes are the measures of true importance in clinical trials.
To quote Cohen30(p.1310), “the primary product of research
is one or more measures of effect size, not p values.  Effect
size measures include mean differences (raw or
standardized), correlations and squared correlations of all
kinds, odds ratios, kappas - whatever conveys the magnitude
of the phenomenon of interest appropriate to the research
context”.
The efficacy of manual therapy may be difficult to test, but
effectiveness is relatively easily measured.  Quality of life
measures are increasingly used as indicators of
effectiveness in clinical trials.  Although HRQOL outcome
measures do not offer an explanation as to the mechanism
of therapeutic action, they do provide broad-based
measures of how a person feels in the physical, mental, and
social aspects of life before, during, and after an
intervention31.
The therapist-patient relationship may be one of the prime
therapeutic aspects of treatment19,32.  It is important,
therefore, to measure the impact of the therapist-patient
relationship, and to control or account for this variable
when assessing the effectiveness of manual therapies.
Because interactions with patients are physical, and social,
and intellectual, and because we cannot separate those
aspects and still conduct a realistic clinical encounter,
manual therapists may be best served by research designs
that gather broad based health data from real patients in
real consultations.  Furthermore, this type of research best
serves patients.  Patients say things like “I want to be able
to read in bed,” or “I just want to be able to cuddle and
carry my grandchildren”.  HRQOL outcome tools ask
questions about how well, how often, and with what
degree of confidence, competence, and comfort, patients
can engage in preferred activities and activities of daily
living.
Perhaps, in keeping with the trend towards reality television,
the research designs of the future will be ‘reality’ research.
Possibly the greatest strength of reality research is that
positive results are directly and immediately applicable to
clinical practice.
CONCLUSION
Rheumatoid and osteoarthritis are common diseases of
substantial morbidity for which there are no known cures.
Arthritis symptoms are associated with poor health-related
quality of life33.  Because these diseases are common,
chronic, and often severe, they are major international
health problems1,6.
Pharmacological intervention and patient-driven exercise
programmes are the mainstay of current therapy for people
with arthritides.  These therapeutic strategies do not meet
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the needs of all patients; some people develop tolerance to
medications; others develop complications and experience
unwanted side-effects, and over 50% of patients are not
psychologically prepared to undertake and complete a
self-driven exercise regime.
Costs of medical care for people with OA and RA may be
underestimated23,25.  Regardless of the precise costs, arthritic
diseases affect in excess of 1 person per 100, and have a
substantial influence on national health budgets.  There is
room to investigate whether manual therapies and exercise
offer viable alternatives, or adjunctive care, for people
with arthritic diseases.  Analysis should include financial
measures as well as HRQOL outcomes.
Manual therapies are practitioner-driven, demanding less
personal discipline from the patient than self-driven
exercise.  Manual therapies comprise procedures of
relatively low risk, with high patient acceptance and
satisfaction, and few side-effects.  It is rational to trial
manual therapies as therapeutic alternatives, or adjuncts,
for people with OA and RA, and compare the HRQOL
outcomes of manual therapies against know effective
therapies (e.g., exercise as therapy).  Furthermore, the
most appropriate research designs for both people with
arthritic disease, and the manual therapies under
examination, are clinically realistic, outcome driven
designs to measure effectiveness.  These research models
closely emulate clinical practice, and measure and report
outcomes of interest to patients and practitioners alike.
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SUMMARY OF IMPORTANT POINTS
• Common arthritides (osteoarthritis and rheumatoid
arthritis) are chronic, progressive diseases which can
substantially degrade health-related quality of life
(HRQOL), producing pain, reduced physical function,
reduced social and work capacity, and negative mood.
• A wealth of literature supports the use of exercise in
arthritis management.  Regular physical exercise has
well documented positive effects of HRQOL.
Appropriate exercise for people with arthritides
include exercise in water (i.e., water aerobics,
swimming), walking, and chair aerobics.
• Despite a lack of research data to support and validate
the use of manual therapy in arthritis management,
many people with arthritis seek this type of care.
Manual therapy may offer a rational approach to
arthritis management for a) those people who are not
psychologically ready to engage in exercise therapy,
b) as an adjunct to exercise therapy, and c) for those
people who are physically unable to engage in exercise
therapy.
Warning:  Because inflammatory arthritides have the
potential to destroy ligaments and render joints unstable,
particularly in advanced rheumatoid disease, manual
therapists are advised to exercise due caution when treating
patients with arthritis.  Rational manual therapies for
people with arthritis include massage and soft tissue
therapies.  In the absence of contrary research data,
mobilisation and manipulation procedures should be
reserved for use on stable joint structures only.
There are appropriate research designs to investigate the
effectiveness of manual therapies in improving HRQOL.
Such designs use HRQOL outcome measures which may
fail to investigate the mechanism of action of a therapy, but
do gather broad based data about how participants feel
before, during, and after therapy.  This type of data about
the physical, mental, and social aspects of health is directly
applicable in day to day clinical practice.
MANUAL THERAPY FOR ARTHRITIS?
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